NOD mice exhibit defects in T cell functions that have been postulated to contribute to diabetes susceptibility in this strain. However, early T cell development in NOD mice has been largely unexplored. NOD mice with the scid mutation and Rag1 deficiency were analyzed for pre-T cell development in the NOD genetic background. These strains reveal an age-dependent, programmed breakdown in ␤ selection checkpoint enforcement. At 5-8 wk of age, even in the absence of TCR␤ expression, CD4 ؉
N onobese diabetic mice spontaneously develop autoimmune type I diabetes that is similar to human disease. Autoimmune diabetes in both humans and NOD mice is physiologically and genetically complex. Approximately 20 loci have been mapped that contribute to diabetes in the NOD mouse (1, 2) . Very few of the diabetogenic genes have been identified, but it is known that T lymphocytes play a central role in pathogenesis (3) .
Although the percentages of immature and mature T cell subsets in NOD mice are minimally perturbed compared with those in other genotypes (4) , functional abnormalities have been reported in various thymic and mature T cell populations from the NOD mouse. Mature T cells from NOD mice display defects in both activation and apoptosis (5) (6) (7) (8) (9) . Immature double-positive (DP) 3 thymic T cells from NOD mice also appear to be less sensitive to apoptotic stimuli (8, 10) , and negative selection of self-reactive DP thymocytes may be aberrant (11) . In addition, NOD mice are reported to have fewer immunoregulatory NKT cells (12, 13) . These observations support the view that the NOD genetic background can predispose to diabetes through a combination of specific regulatory alterations in function. However, they leave open the question of whether the behavior of these cells, particularly at selection, is a consequence of defects in T cell precursors at the earliest stages of development.
Mice unable to complete TCR and BCR rearrangements, e.g., those homozygous for the Prkdc scid (scid) mutation or for ablation of one of the Rag genes, provide useful access to both immature lymphoid precursors and the recombination-dependent checkpoint mechanisms in lymphocyte development (14) . Such immunodeficient mice accumulate specific precursor T cell populations in the thymus that are incapable of rearranging a TCR ␤-chain and therefore cannot proceed with normal T cell development, remaining CD4 Ϫ CD8 Ϫ double negative (DN). The DN cells differentiate through a succession of well-marked stages with increasing commitment to the T lineage: first CD44 ϩ CD25 Ϫ (DN1), which retain the ability to give rise to NK and dendritic cells, then CD44 ϩ CD25 ϩ (DN2), then CD44 Ϫ CD25 ϩ (DN3), when they are fully committed to the T lineage, but there they arrest.
The arrest of the cells at the DN3 stage is itself a response to T cell-specific checkpoint control functions, called ␤ selection, which assay the cells for correct assembly of a pre-TCR signaling complex with the product of a rearranged TCR ␤-chain gene (15) . After early proliferation dependent on IL-7 and Kit ligand (stem cell factor), rearrangement of the TCR␤ locus is initiated at DN2 or DN3 and development is halted at DN3 until a productive TCR␤ is made. If a TCR␤ protein is made that can pair with pre-T␣ and CD3 components already present in the cell, signaling commences and induces rapid proliferation and a cascade of gene expression changes. These include loss of surface CD25, transcription and expression of CD8 and CD4, protection from apoptosis, allelic exclusion at the TCR␤ locus, and initiation of TCR␣ germline transcription and rearrangement. Failure to make a properly rearranged TCR␤ normally results in cell death without further differentiation, unless components of the checkpoint control system are manipulated (reviewed in Ref. 16 ). This early differentiation programming establishes the signaling machinery to be used for positive and negative selection, when signal strength appears to play a critical role. Variations in differentiation at these TCR-independent stages could then have a profound impact upon later TCR-dependent developmental decisions.
To determine whether NOD mice exhibit any defects in T cell development before the TCR-dependent events of positive and negative selection, we have conducted a detailed analysis of thymocytes from the immunodeficient strains of NOD mice with the scid mutation (17, 18) or Rag1 deficiency (19) . In this study we report that both NOD-scid and NOD-Rag1 null mouse thymocytes spontaneously break through the ␤ selection checkpoint at ϳ5-8 wk of age, generating CD4 ϩ single-positive (SP) and CD4 ϩ CD8 ϩ DP, TCR-negative cells. These breakthrough cells fail to restore thymic cellularity and show some, but not all, traits of normal ␤-selected cells, indicating a significant breakdown of developmental coordination and checkpoint control in the NOD genetic background. 
Materials and Methods

Mice
Flow cytometric staining and cell sorting
Single-cell suspensions of thymocytes were blocked with anti-Fc Abs and stained on ice in 96-well, U-bottom plates as described previously (20) . The following conjugated Abs were used for cell surface staining: CD25, CD4, CD44, CD8, CD2, CD4, CD8, IL-7R␣ (BD Pharmingen, San Diego, CA), and CD117 (c-Kit; eBiosciences, San Diego, CA). Anti-TCR␤-allophycocyanin and BclII-FITC (BD Pharmingen) and the BD Cytofix/Cytoperm Kit (BD Biosciences, Mountain View, CA) were used for intracellular staining. FACS analyses were performed using a FACSCalibur (BD Biosciences). Thymocyte subsets were sorted using a FACSVantage Cell Sorter (BD Biosciences).
Results
Thymocytes from 6-to 8-wk-old NOD-scid and NOD-Rag null mice spontaneously break through the ␤ selection checkpoint
Unable to complete the rearrangement of the TCR␤ locus, thymocytes from 4-wk-old NOD-scid mice arrest in the CD44 Ϫ CD25 ϩ CD4 Ϫ CD8 Ϫ (DN3) stage of development, like those of B6-scid mice, at the ␤ selection checkpoint, (Fig. 1A, top panels) . However, by 6 wk of age NOD-scid thymocytes spontaneously break through the ␤ selection checkpoint, developing CD4 ϩ cells, CD4 ϩ CD8 ϩ DP cells, or both (Fig. 1B) . The breakthrough cells are negative for detectable surface CD3 or intracellular TCR␤ (data not shown). Despite this dramatic breakthrough, thymus sizes remain small, and total cell numbers (given above CD4 vs CD8 plots) are comparable between age-matched NOD-and B6-scid mice, indicating that the developing cells fail to proliferate, fail to survive, or both.
Although the scid defect is intrinsically "leaky" and occasionally permits a TCR␤ rearrangement, Rag1-or -2 null mutations completely block rearrangement. For this reason, thymocytes from NOD-Rag1 null mice at various ages were also analyzed. Thymocytes from these animals also show an age-dependent breakthrough, similar to that of NOD-scid mice. Development at 6 wk and younger is similar to that of B6-Rag2 null thymocytes (Fig. 1C) . However, at ϳ8 wk of age CD4 ϩ SP and CD4 ϩ CD8 ϩ DP cells first appear in NOD-Rag null thymuses (Fig. 1D) . Again, intracellular TCR␤ is not detected (data not shown), and the thymus sizes and cell numbers are not very different from those of control B6-Rag null thymuses. Thus, the breakthrough phenotype is a characteristic of early T cells on the NOD genetic background, which is revealed by mutations that inhibit TCR gene rearrangement.
The phenotypes of the breakthrough thymocytes are similar in both strains and somewhat unusual. First, the CD4 ϩ SP cells appear to be immature transitional cells between DN and DP cells. Such immature single positives (ISP) are normally CD8 ϩ in most commonly studied mouse strains, such as B6, or acquire CD4 and CD8 together (e.g., as in wild-type NOD (M. A. Yui and E. V. Rothenberg, unpublished observations)). Second, the expression of CD4 occurs without full down-regulation of CD25 (Fig. 1, B and  D) . This atypical phenotype is especially prominent in the CD4 ISP breakthrough cells, which preserve a DN-like CD44/CD25 staining pattern (Fig. 1, B and D) . Third, the down-regulation of CD25 that does occur in the breakthrough cells usually begins in cells that retain some CD44, as if undergoing a direct DN2 to DN4 transition (Fig. 1 , B and D), although this is variable between individual animals. All these results contrast with most mouse strains, in which the gains and losses of CD44, CD25, CD8, and CD4 expression from DN2 to DP occur in distinct, sequential steps. Thus, in the NOD immune-deficient thymus, landmark stages of early T cell development appear to overlap and become generally disordered.
Thymic lymphomas, composed of TCR-negative DP and/or CD8 ϩ cells, were observed in two of three NOD-Rag null mice Ͼ4 mo of age (Fig. 1E) . Such thymuses were large, with 20 -30 ϫ 10 6 DP and/or CD8 SP cells. Thymic lymphoma formation has been found in NOD-Rag2 null cells previously (21) and is well known to occur in NOD-scid mice, where it is the primary cause of mortality in this strain (17) . Most of these reported thymic lymphomas consist of CD4 ϩ CD8 ϩ TCR-negative cells. Although the focus of this report is on the alterations of thymocyte differentiation observed at ages when frank thymomas are rare, the early loss of ␤ selection checkpoint control may be one of the initiating steps in tumorigenesis in these strains.
Breakthrough is age-dependent and genetically recessive
A summary of the percentages of CD4 ϩ SP and DP cells in individual animals of the various immunodeficient B6 and NOD strains at different ages is shown in Fig. 1F . One outcome of ␤ selection is a rapid entry into cell cycle and proliferation, especially in the ISP stage, resulting in an increase in cell size and 50-to 100-fold increases in thymic cell numbers. As shown in Fig. 1 , A-D, thymic cell numbers in the immunodeficient NOD mice do not significantly increase during breakthrough. Few of the immunodeficient NOD breakthrough CD4
ϩ ISP cells are as FIGURE 1. Spontaneous ␤ selection checkpoint breakthrough in NOD-scid and NOD-Rag null thymocytes. CD4 vs CD8 and CD44 vs CD25 profiles of thymocytes from 8-wk-old B6-scid and 4-wk-old NOD-scid mice (A) and 8-wk-old B6-Rag null and 6-wk-old NOD-Rag null mice (C), showing typical arrest at the ␤ selection checkpoint at the DN3 (CD4 Ϫ CD8 Ϫ CD25 ϩ CD44 Ϫ ) stage of development. Thymocytes from 6-to 9-wk-old NOD-scid mice (B) and 8-to 10-wk-old NOD-Rag1 null mice (D) exhibit breakthrough CD4 ϩ and CD4 ϩ CD8 ϩ DP cells. CD25 and CD44 profiles of these cells are also shown for total thymocytes (All) or after gating on CD4 large as normal B6 CD8
ϩ ISPs (Fig. 1G , left histogram), but they include a subset of large blasts (based on forward light scatter), suggesting that some of the cells are actively cycling. Similarly, the immune-deficient NOD DP cells include a population of larger, lymphoblastic cells as well as a population of smaller cells that are just slightly larger than the postmitotic DP cells from wild-type B6 mice (Fig. 1G , right histogram). Thus, despite some level of blastogenesis, it appears that the DP cells die before or just after withdrawing from cell cycle.
Bcl-x L expression increases, whereas Bcl2 expression declines, in NOD-scid and -Rag null breakthrough thymocytes: similarities to normal ␤ selection
To dissect the nature of the breakthrough phenomenon, we evaluated a series of functionally important gene products that are induced or down-regulated in normal ␤ selection. After ␤ selection, Bcl2 levels normally decline and remain low in DP thymocytes (22, 23) , whereas Bcl-x L expression dramatically increases and becomes the critical antiapoptotic factor (24) . To determine whether abnormally high amounts of Bcl-2 might contribute to the ␤ selection breakthrough, intracellular Bcl-2 was measured by FACS analysis of immunodeficient NOD thymocyte populations. The NOD-scid and -Rag null breakthrough cells exhibited a decline in intracellular Bcl-2 when surface CD4 was up-regulated, with a further decrease in the DP stage ( Fig. 2A, middle and right panels) . To determine whether these changes reflect ongoing synthesis, RNA levels were assessed in breakthrough thymocyte subsets by quantitative real-time Q-PCR analysis. DN2, DN3, ISP (CD4 ϩ ), and DP populations were FACS purified from pools of NOD-scid and -Rag null thymocytes and compared both with control DN2 and DN3 populations from B6-scid and -Rag null mice and with control DN3, ISP (CD8 ϩ ) and DP cells from B6-Mhc null mice. B6-Mhc null cells were used as controls for the TCR-negative breakthrough cells because they undergo normal ␤ selection and development of DP cells without proceeding to TCR/MHC-dependent positive or negative selection (25) . Using ␤-actin for normalization, Bcl2 gene transcription, like protein expression, was found to decline in NOD thymocytes during differentiation from DN3 to DP (Fig. 2B, top  panel) . The same immunodeficient NOD thymocyte samples were also found to increase Bcl-x L expression, although levels were never as high as in Mhc null controls (Fig. 2B, middle panel) . Looking at ratios of Bcl-x L to Bcl2, which removes ␤-actin normalization artifacts, the breakthrough immunodeficient NOD cells followed a pattern similar to that of thymocytes from B6-Mhc null control mice undergoing normal ␤ selection, with a delay in the atypical NOD ISP phase and a dramatic increase of ϳ100-fold by FIGURE 2. Bcl-2 levels decline and Bcl-x L levels increase in immunodeficient NOD breakthrough cells. A, Intracellular Bcl2 staining of breakthrough cells. Thymocytes from B6, B6-scid, NOD-Rag null , and NOD-scid mice were stained for surface CD4 and CD8, followed by intracellular Bcl-2 (icBcl2) staining. CD4 vs CD8 plots (left panels) and CD4 vs icBcl-2 (middle panels) are shown for each mouse strain along with fluorescence histograms for icBcl2, gated on DN, ISP, and DP populations based upon CD4 and CD8 expression (right panels). Tinted histograms are isotype controls. B, Scatter plots showing the relative amounts of Bcl2 (top panel) and Bcl-x L (middle panel) mRNA normalized with ␤-actin, and Bcl-x L relative to Bcl2 mRNA (bottom panel) in the same samples. Gene expression was measured by Q-PCR on RNA from sorted DN2 (
, and CD4 ϩ CD8 ϩ DP populations from NOD-scid and -Rag null mice; DN2 and DN3 cells from B6-scid and Rag null , and DN3, ISP (CD8 ϩ ); and DP cells from B6-Mhc null mice. Data from two or three independent pooled samples are included for each strain and subset.
the DP stage (Fig. 2B, bottom panel) . This demonstrates that the general regulatory patterns of expression of these critical antiapoptotic genes are maintained in the NOD breakthrough cells, and part of the differentiation program in these cells is the up-regulation of Bcl-x L transcription.
Similarities to normal ␤ selection: expression of germline TCR␣ transcription and surface CD2 in breakthrough NOD-Rag null and -scid cells
One hallmark outcome of ␤ selection is the transcription of C␣ that accompanies the opening of the TCR␣ locus to recombination (26) . Comparing sorted thymocyte subsets from the different mouse strains by Q-PCR, C␣ transcription was not detected in DN2 and DN3 subsets from immunodeficient NOD or B6 mice, whereas expression was found in control B6-Mhc null ISP and DP cells, as well as some low level expression in the Mhc null DN3 population, which includes some cells beginning ␤ selection. In these analyses, breakthrough NOD-Rag null DP cells and NOD-scid CD4 ϩ and DP cells expressed germline TCR-C␣ transcripts similarly to the control ISP cells (Fig. 3A) .
CD2 is typically up-regulated after ␤ selection (27) . Like control B6-Mhc null ISP and DP cells, NOD-Rag null and -scid breakthrough CD4
ϩ ISP and DP cells showed a dramatic increase in CD2 fluorescence relative to the DN cells (Fig. 3B) . Furthermore, the mean fluorescence levels of surface CD2 expressed in most populations of NOD-Rag null as well as NOD-scid cells were even higher than those observed in control cells (Fig. 3C) . These results show that both C␣ and CD2 are induced in NOD breakthrough cells, demonstrating that several more aspects of the normal post-␤ selection differentiation program are initiated in the breakthrough cells.
Breakthrough NOD-scid and -Rag null thymocytes have high levels of surface c-Kit and IL-7R␣ expression: distinction from normal ␤ selection
The mechanisms exerting checkpoint control in normal mice are thought to include a default apoptotic pathway from which pre-TCR signaling rescues the cells (28) . Thus, any gene products that could provide survival signals aberrantly were of special interest. The growth receptors for stem cell factor, c-Kit (CD117), and IL-7, IL-7R␣, are critical for the survival and proliferation of cells in the DN stages of T cell development, but not after ␤ selection (29) . c-Kit levels are normally highest in DN1 and DN2 cells and decline from DN2 to DN3, with levels remaining low in most ISP and DP cells. This decline could be important for the normal shift in the survival requirements of the cells, from cytokine dependence to pre-TCR dependence. In the NOD-Rag null thymocytes, surface expression of c-Kit in breakthrough CD4 ϩ and DP cells was much higher than that in normal B6-Mhc null ISP and DP thymocytes (Fig. 4A) . Mean fluorescence values from NOD-Rag null and -scid subsets showed that whereas levels of c-Kit in NOD-Rag null breakthrough cells were much higher than those in control cells, NODscid levels of c-Kit were only slightly higher than those in control subsets (Fig. 4B) , although the latter observation was consistent, especially in early breakthrough cells (data not shown). The differences in c-Kit expression in NOD-scid vs -Rag null cells may be related to the more complex mechanism of developmental arrest and cell death in the scid mutant generally (14) .
Although surface IL-7R␣ levels declined somewhat after ␤ selection in normal cells, surface expression of IL-7R␣ in breakthrough CD4
ϩ and DP NOD-Rag null thymocytes was again higher than that in normal B6-Mhc null ISP and DP thymocytes (Fig. 4A ). Mean fluorescence values from NOD-Rag null and -scid cells showed that in all subset populations from both NOD strains, values were much higher than those in control cells, with the peak in expression occurring in the CD4 ϩ ISP cells (Fig. 4B) . Thus, c-Kit and IL-7R␣ levels in breakthrough cells appear to be at least initially higher than those in normal ␤-selected cells in both immunodeficient NOD strains. To determine whether this unusual level of surface c-Kit and IL-7R␣ expression reflects ongoing synthesis, Q-PCR was performed on the same samples used for Bcl2, Bcl-x L , and TCR-C␣ RNA analysis. The c-kit and IL-7R␣ genes were expressed at high levels in the DN2 and DN3 cells from B6-Rag null and B6-Mhc null mice as well as in these subsets from immunodeficient NOD mice. However, although the c-kit and IL-7R␣ mRNA levels declined precipitously in the ISP and DP cells from B6-Mhc null mice, they remained high in all ISP from NOD-scid and NOD-Rag null mice (Fig. 4C) . The c-kit and IL-7R␣ mRNA levels in DP samples from immunodeficient NOD mice were more variable, although levels of IL-7R␣ in particular were still much higher than those of Mhc null DP cells, which were undetectable. These data support the FACS data showing that c-kit and IL-7R␣ levels are both unusually high in the immunodeficient NOD cells, especially in the CD4 ϩ early breakthrough cells.
Some, but not all, gene expression changes typical of ␤ selection occur during differentiation of breakthrough immunodeficient NOD cells
To begin to dissect the causes and outcomes of the checkpoint breakthrough in the immunodeficient NOD cells, expression patterns of a number of other genes expressed in early thymocytes were analyzed by Q-PCR, using the same samples shown previously. These analyses were designed, on the one hand, to examine the status of functions that have been implicated in other cases of checkpoint violation and, on the other hand, to define subsets of coordinately regulated events within the complex set of ␤ selection responses.
Three transcription factors expressed in DN cells, the bHLH factors HEB-alt (a 5Ј splice isoform of HEB) (M. K. Anderson and E. V. Rothenberg, unpublished observations) (30) and Hes1, and an Ets factor, SpiB, all declined precipitously in the transition from DN3 to ISP/DP stages in B6-Mhc null cells as they undergo ␤ selection (Fig. 5) . However, none of these factors exhibited the same magnitude of decline in the NOD breakthrough cells. Levels of mRNA of HEB-alt decreased only slightly in the NOD breakthrough cells, while declining to almost undetectable levels after ␤ selection in control cells. Hes1 also displayed a modest decline in transcription in NOD CD4
ϩ and DP breakthrough cells at a time Fig. 2 . ␤-Actin levels were used for normalization. nd, not detected. Subsets with detectable differences in levels between NOD and controls are boxed.
of precipitous decrease in expression in normal control ISP and DP cells. The Ets-related transcription factor, SpiB, normally expressed only transiently in the DN3 stage of development, was not only higher initially in immunodeficient NOD DN3 cell populations than those from most control mice, but also failed to decline in NOD breakthrough cells and was even elevated in many cases. These results, along with data for c-kit and IL-7R␣, show that negative transcriptional changes that occur during normal ␤ selection take place much more slowly, if at all, in NOD breakthrough cells.
Genes that fail to show clear differences between subsets from immunodeficient NOD and control B6 animals include Ikaros, which is implicated in tumor suppression and checkpoint control (31); another transcription factor critical for T cell development, Gata3 (32, 33) ; and Pim1 and p53, known to play roles in ␤ selection and thymic lymphoma formation (34 -36) (Fig. 5 ).
An additional set of genes with known or suspected roles in ␤ selection checkpoint control, apoptosis, and/or thymic lymphoma formation was assayed for evidence of major dysregulation at the RNA level. These include pre-T␣, pro-and antiapoptotic factors However, none of these exhibited obvious or consistent differences between immunodeficient NOD cells and controls, either pre-or postbreakthrough (data not shown).
Breakthrough CD2
ϩ c-Kit
cells emerge before overt CD4 up-regulation and can occur at DN2 or DN2-DN3 transitional stages
Examining the timing of the developmental defect in more detail, thymocytes from 4.5-, 6-, and 7.5-wk-old mice were analyzed in comparison with cells from 8-wk-old B6-Rag null and TCR-negative cells from B6-Mhc null mice. Thymocytes from 4.5-and 6-wkold NOD-Rag null mice looked much like those from B6-Rag null mice, except for somewhat higher levels of CD4 (Fig. 6A) . Although the levels of CD4 were not different between 4.5-and The same immunodeficient NOD and control subsets were used as described in Fig. 2B . ␤-Actin levels were used for normalization. Subsets with detectable differences in levels between NOD and control cells are boxed.
6-wk-old mice, gating on CD4 int-high populations, a distinct subpopulation, expressing high levels of both c-Kit and IL-7R␣, appeared in 6-wk-old mouse cells that was not present in 4.5-wk-old mice (Fig. 6A, long arrow) . At 7.5 wk of age, this cytokine receptor high population was seen distinctly in the DN subset as well as the CD4 high cells (Fig. 6A, short arrows) . Examining the DN subsets from the same mice using pre-T cell markers CD44 and CD25 as well as CD4, a small subset of CD44 Ϫ CD25 ϩ DN3-like (DN3) cells appeared in 6-wk-old NODRag null animals that were intermediate for CD4, but high for CD2 and c-Kit, before an obvious breakthrough of CD4 ϩ cells was observed (Fig. 6B, long arrows) . CD44 ϩ CD25 ϩ DN2-like (DN2) populations from 6-wk-old animals looked very much like DN2 cells from 4.5-wk-old NOD-Rag null cells and 8-wk-old B6-Rag null cells (Fig. 6B) . However, at 7.5 wk, the DN2 and DN3 populations also contain a subset of CD4 ϩ c-Kit ϩ CD2 ϩ cells (Fig.6B , short arrows) in addition to a conventional DN3 population of cells that are lower for all these markers, like cells from younger animals and B6 controls. Even at 4.5 wk of age, DN3 cells from NODRag null mice had a slightly higher percentage of CD2 ϩ and c-Kit ϩ thymocytes than those from B6-Rag null mice, suggesting that the cells may arise even earlier. Taken together, these results show that there is a cohort of cells present in the thymus emerging before 6 wk of age that fails to undergo normal DN developmental pathways found in B6-Rag null mice. Some of these cells can be distinguished by the retention of some DN2-like characteristics (high levels of surface CD44, c-Kit, and IL-7R␣) as well as the acquisition of surface CD2 and CD4. These results suggest that the breakdown in developmental programming may be initiated at the DN2 or DN2-DN3 transitional stage rather than only after prolonged survival at the DN3 stage.
Discussion
The scid mutation and Rag deficiency reveal that the NOD genetic background confers a fundamental defect in early T cell development and checkpoint control. Although these mutations, on a normal B6 or CB.17 genetic background, block development at the ␤ selection checkpoint, thymocytes from both NOD immunodeficient strains spontaneously break through this checkpoint. At ϳ5-7 wk of age CD4 ϩ and CD4 ϩ CD8 ϩ DP cells appear in the thymuses of both NOD strains. Although some differences in the precise timing and gene expression patterns occur between NODscid and NOD-Rag null breakthrough thymocytes, the overall patterns are the same and demonstrate that the defect is due to the NOD genetic background. Furthermore, both NOD immune-deficient strains are prone to thymic lymphomas, which are often CD4 ϩ CD8 ϩ DP and may have their origins in these breakthrough cells.
Manipulations that allow cells to develop beyond the DN3 stage without a pre-TCR fall into three general categories. First, cells with the scid or Rag null mutations or any other pre-TCR defect can undergo a fairly normal ␤ selection process in response to the triggering of an Lck/MAPK/protein kinase C signaling cascade, mimicking the pre-TCR (15) . These options include cross-linking with anti-CD3 Abs, which can initiate a TCR signal even without a TCR␤ protein (37) , deletion of the Lck inhibitory kinase, Csk (38) , or expression of constitutively activated Lck (39) . These models result in all the normal outcomes of ␤ selection and restoration of thymocyte cell numbers. Second, at the opposite extreme, loss of Runx1 or Brg leads to an appearance of prematurely CD4 ϩ cells without any other features of normal ␤ selection due to a specific failure of CD4 repression (40, 41) . Finally, a partial rescue can be obtained by alterations that do not reproduce the full pre-TCR signal. Bcl-2 overexpression (23), p53 deficiency (35, 36, 42) , Ikaros deficiency (31), constitutively active NF-B (43), and dominant negative Fadd (44) each allow differentiation of Rag null cells, but with little or no proliferation or cell accumulation. These breakthroughs appear to be due to transient antiapoptotic functions, bypassing the need for pre-TCR signaling for survival, but inadequate to produce a full proliferative response. As in the latter examples, the NOD defect in ␤ selection checkpoint control induces many specific aspects of ␤ selection, but does not support strong proliferation and accumulation of DP cells, suggesting an antiapoptotic component. Mature TCR-positive cells and DP thymocytes from wild-type NOD mice are known to be resistant to some forms of cell death, and this defect is postulated to be involved in the generation of autoimmunity (7, 8, 10, 45) . Furthermore, the high frequency of thymomas in both NOD-scid (17) and NOD-Rag null mice (Ref. 21 and this study) as well as the presence of tumors in older NOD mice that do not die from diabetes (46) support the idea that checkpoint control and apoptosis are abnormal in NOD mice. The results presented in this study could extend that relative death resistance back to the earliest stages of T cell development.
The elevated expression of c-Kit and IL-7R␣ growth factor receptors may contribute to survival signals, although they normally do so via induction of Bcl-2 expression, which is not maintained in the breakthrough cells. Control of apoptosis vs survival in T cells and other cells is very complex, with many different genes and pathways impacting on the outcome. Although transcription of the molecules implicated in other similar cases of checkpoint violation, such as p53, Cflar/Flip, Fadd, and Bcl2, do not appear to be dramatically affected, we cannot rule out more subtle variations in the expression of these genes at key developmental points or mutational and posttranslational effects.
The breakthrough may include failure of a cell death mechanism that normally limits the life span of the DN3 thymocytes. However, the developmental abnormalities can appear at an earlier stage, before CD44, c-Kit, and IL-7R␣ are down-regulated, at the DN2 or DN2-DN3 transitional stages. This suggests that the defect is not simply due to prolonged survival at the DN3 stage. Furthermore, the overall gene expression pattern induced during breakthrough is clearly atypical, indicating a basic decoupling of ␤ selection program components.
Our detailed analyses enable us to distinguish between specific components of the differentiation program initiated in NOD early T cells that do and do not follow the program of normal ␤-selected cells. Fig. 7 summarizes the similarities and differences in the timing and expression of landmark surface markers and other genes known to change around the time of ␤ selection between immunodeficient NOD breakthrough cells and control immunodeficient and normal cells on a B6 background. CD4, CD8, CD2, Bcl-x L , and Tcr-C␣ all increase in expression in the breakthrough cells, mimicking normal thymocytes, although the timing may differ. The shift to a high Bcl-x L :Bcl2 ratio with differentiation occurs, although again there is some delay in the NOD breakthrough cells, suggesting a closer linkage with CD8 expression (by induction) (47) than with CD4 expression (by derepression) (40) . The expression of c-kit and IL-7R␣ is high in early breakthrough cells and remains high, in NOD-Rag null cells in particular. However, several other genes whose expression normally drops sharply after ␤ selection are still maintained at fairly high levels in the NOD CD4 ϩ ISP breakthrough cells, including CD25 and the transcription factors HEB-alt, SpiB, and Hes1. The differences in rates of proliferation occurring in normal ␤-selected cells vs NOD breakthrough cells may play a role in this failed down-regulation, because the high rate of proliferation seen in ␤-selected cells, but not breakthrough cells, may help to dilute out both surface receptors and extant pools of mRNA. However, this cannot be the whole story for SpiB, which appears to be up-regulated in the ISP cells of the NOD-scid and NOD-Rag null mice. Although SpiB overexpression in T cell progenitors can favor the development of plasmacytoid dendritic cells (48) , the normal role for transient SpiB expression in normal DN3 cells is not known.
Together this panel of genes shows that the immunodeficient breakthrough cells initially maintain many gene expression characteristics of the DN2/3 progenitor cells while initiating the expression of new genes characteristic of cells receiving a pre-TCR signal to progress through ␤ selection. The specific pattern of alterations we document in this study gives the NOD breakthrough phenotype a distinctive molecular signature. An extension of this gene expression approach to other models would provide the tools to compare the mechanisms of the NOD form of breakthrough with those of specifically targeted genetic perturbations in checkpoint control.
The expression of the adhesion and signaling molecule, CD2, in the earliest breakthrough cells is particularly intriguing. CD2 can play an important role in TCR signaling by setting quantitative thresholds for Ag responsiveness (49) and in pre-TCR signaling (50) . Whether CD2 expression contributes to or is a consequence of a partial pre-TCR signal in the immunodeficient NOD breakthrough cells will require further investigation. Furthermore, in preliminary experiments we find that CD2 levels in most wild-type NOD subsets are higher than levels in similar populations from B6 thymuses, and this difference may be age-dependent (M. A. Yui, unpublished observations), a characteristic that could affect thymic selection and tolerance induction. Thus, phenomena observed in the earliest stages of development in TCR-negative immunodeficient NOD strains may have relevance for differentiation and mature cell functions in wild-type NOD mice.
There appears to be a close relationship between the breakthrough phenotype and the development of thymic lymphomas in the immunodeficient NOD animals. Thymic lymphomas were reported to be predominantly TCR-negative and either DP or CD8 ϩ in NOD-scid (17) and NOD-Rag null mice (21) . We also observed thymic lymphomas in two of three 4-mo-old NOD-Rag1 null mice in this study. A previous study showed linkage between the large thymic lymphomas in NOD-scid mice and an endogenous ecotropic retrovirus, Emv30 (17) , which was subsequently found to affect the progression, but not the initiation of thymic lymphomas (51) . To check whether the breakthrough phenotype in NOD-scid and -Rag null mice maps to this locus, we analyzed (NODscidϫB6-scid)F 1 and F 1 ϫNOD-scid backcross mice. The trait appears to be genetically recessive, because F 1 mice did not exhibit the breakthrough phenotype despite having an expressible copy of Emv30. Furthermore, in a preliminary analysis of 58 backcross mice the trait did not correlate with the presence of two copies of the gene (data not shown), further ruling out Emv30 as the genetic source of the breakthrough phenotype. The precedents of E2a and Ikaros knockout mice (31, 52) support the inference that ␤ selection violation in itself can be the source of susceptibility to thymic lymphoma.
These defects in ␤ selection, revealed by mutations in TCR recombinational machinery, suggest a new class of abnormality in thymocyte development that could contribute to diabetogenesis in wild-type NOD mice. The exact relationships among these processes remain to be worked out. Our findings demonstrate that T cells developing postnatally in the NOD mouse may have derangements in their differentiation and responses to checkpoint controls from the earliest stages of development. Although the developmental defect is revealed by immunodeficiency, the underlying genetic and molecular natures of this defect are shared by wildtype NOD precursor T cells, with unknown effects in the presence of ongoing TCR rearrangement. Because many of the same molecular pathways are required at ␤ selection and during subsequent T cell differentiation, subtle differences in signaling and survival at critical early stages of development may set aberrant thresholds for later T cell responses to selecting, activating, and apoptotic signals. The higher levels of CD2 seen in breakthrough cells as well as normal NOD cells may be among these factors. These immunodeficient NOD strains should provide an excellent model system in which to study a unique defect in early T cell differentiation programming, ␤ selection checkpoint control, and thymic lymphoma development.
